ASCO

Audio Journal of Oncology in Advance - November 15th, 2006

November 15, 2006 ⋅ Post a comment
Daniel Petrylak
Daniel Petrylak
Oliver Sartor
Oliver Sartor
Mark Socinski
Mark Socinski
 Kanti Rai
Kanti Rai		 Edward Ambinder
Edward Ambinder

Chemo- and Immunotherapy Working Together in Hormone Refractory Prostate Cancer

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
DANIEL PETRYLAK, Columbia Presbyterian Medical Center, New York
COMMENT: EDWARD AMBINDER, Mount Sinai School of Medicine, New York
In hormone refractory prostate cancer, chemotherapy and immunotherapy can work together - and the next task is to work out how best to combine them. Daniel Petrylak of the Columbia Presbyterian Medical Center in New York had the details.

Satraplatin for Hormone Refractory Prostate Cancer

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
OLIVER SARTOR, Dana-Farber Cancer Institute, Boston
COMMENT: EDWARD AMBINDER, Mount Sinai School of Medicine, New York
According to Oliver Sartor of the Dana-Farber Cancer Institute in Boston, the platinum agent satraplatin is a possible new treatment for androgen-independent prostate cancer.

Paclitaxel Poliglumex More Effective in Women with Non Small-Cell Lung Cancer?

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
MARK SOCINSKI, University of North Carolina, Chapel Hill
Paclitaxel linked to a polyglutamate backbone could work better in women – but some new evidence has raised concerns for investigators. Mark Socinski of the University of North Carolina in Chapel Hill shared the data in New York.

Antisense Therapy Shows Promise in Chronic Lymphocytic Leukemia

REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
KANTI RAI, Long Island Jewish Medical Center, New York
COMMENT: EDWARD AMBINDER, Mount Sinai School of Medicine, New York
Kanti Rai of the Long Island Jewish Medical Center in New York has had encouraging results from adding the antisense molecule Genasense to chemotherapy, in patients with relapsed or refractory CLL.


To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.

Similar Interviews

  • Audio Journal of Oncology in Advance - April 15th, 2007 - Bisphosphonates Recommended for Lung Cancer Bone Metastases

    • PETER HARPER, Guy’s Hospital, London REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville Bisphosphonates may be

  • When Good Cells Go Bad: The Stem Cell Origin of Cancers

    • DAVID JABLONS, University of California, San Francisco REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain Cell signalling

  • Audio Journal of Oncology in Advance - January 15th, 2007 - HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

    • IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast

    Post a comment

    Health For All 30 Years After Alma Ata? Mental Health And War»
    AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
    Two important symposia have been held in London to discuss healthcare issues posing significant dilemmas to world leaders in the 21st Century. "The Future of Primary Health Care" was attended by public health experts from around the Globe to assess the best options for improving primary health care in the future. It was held on the 30th anniversary of the Alma Ata Declaration made in 1977 which was intended as a blueprint for health provision and identified primary health care as the means through which the global goal of "Health for All" could be achieved. The second meeting, on "Mental Health in Fragile States", was held to raise the profile of mental health care in zones where conflict has taken place or is still happening. Analyses of the key issues and how to deal with them effectively were discussed by top experts from the London School of Hygiene and Tropical Medicine and associated organisations. Peter Goodwin attended both meetings and talked with some of the key speakers.
    LSHTM Audio News: British Association Special Edition»
    Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
    Peter Goodwin hears from London School of Hygiene and Tropical Medicine experts speaking at the annual science festival of the British Association for the Advancement of Science held in Liverpool, September 6-10, 2008, and from recent scientific publications on: the health impact of global warming, a tropical virus reaching temperate zones, inequalities in cancer outcomes, how eating oily fish can save your eyesight, and free internet publishing scientific journals.
    Subscribe to Audio Medica Podcast